Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment: The TERAVOLT Experience.
Cancer Cell
; 38(5): 602-604, 2020 11 09.
Article
in English
| MEDLINE | ID: covidwho-970849
ABSTRACT
To understand the real impact of COVID-19 on cancer patients, an entirely new data collection effort was initiated within the Thoracic Cancers International COVID-19 Collaboration (TERAVOLT). TERAVOLT reported high mortality related to COVID-19 infection in thoracic cancer patients and identified several negative prognostic factors. In this commentary, we discuss the importance and limits of patient registries to support decision-making in thoracic cancer during the SARS-CoV-2 pandemic.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Thoracic Neoplasms
/
Practice Guidelines as Topic
/
Coronavirus Infections
/
Clinical Decision-Making
/
Global Burden of Disease
/
Betacoronavirus
Type of study:
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Cancer Cell
Journal subject:
Neoplasms
Year:
2020
Document Type:
Article
Affiliation country:
J.ccell.2020.10.002
Similar
MEDLINE
...
LILACS
LIS